Your browser doesn't support javascript.
loading
What about tocilizumab? A retrospective study from a NYC Hospital during the COVID-19 outbreak.
Mehta, Monica; Purpura, Lawrence J; McConville, Thomas H; Neidell, Matthew J; Anderson, Michaela R; Bernstein, Elana J; Dietz, Donald E; Laracy, Justin; Gunaratne, Shauna H; Miller, Emily Happy; Cheng, Jennifer; Zucker, Jason; Shah, Shivang S; Chaudhuri, Shaoli; Gordillo, Christian A; Patel, Shreena R; Guo, Tai Wei; Karaaslan, Lara E; Reshef, Ran; Miko, Benjamin A; Bathon, Joan M; Pereira, Marcus R; Uhlemann, Anne-Catrin; Yin, Michael T; Sobieszczyk, Magdalena E.
Afiliação
  • Mehta M; Department of Pharmacy, NewYork-Presbyterian Hospital, Columbia University Irving Medical Center, New York, New York, United States of America.
  • Purpura LJ; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York, United States of America.
  • McConville TH; ICAP, Mailman School of Public Health, Columbia University, New York, New York, United States of America.
  • Neidell MJ; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York, United States of America.
  • Anderson MR; Department of Health Policy and Management, Mailman School of Public Health, Columbia University, New York, New York, United States of America.
  • Bernstein EJ; Division of Pulmonary Critical Care, Department of Medicine, Columbia University Irving Medical Center, New York, New York, United States of America.
  • Dietz DE; Division of Rheumatology, Department of Medicine, NewYork-Presbyterian Hospital, Columbia University Irving Medical Center, New York, New York, United States of America.
  • Laracy J; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York, United States of America.
  • Gunaratne SH; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York, United States of America.
  • Miller EH; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York, United States of America.
  • Cheng J; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York, United States of America.
  • Zucker J; Department of Pharmacy, NewYork-Presbyterian Hospital, Columbia University Irving Medical Center, New York, New York, United States of America.
  • Shah SS; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York, United States of America.
  • Chaudhuri S; Division of Infectious Diseases, Department of Pediatrics, Columbia University Irving Medical Center, New York, New York, United States of America.
  • Gordillo CA; Department of Medicine, Columbia University Irving Medical Center, New York, New York, United States of America.
  • Patel SR; Blood and Marrow Transplantation Program, Columbia University Irving Medical Center, New York, New York, United States of America.
  • Guo TW; Division of Pulmonary Critical Care, Department of Medicine, Columbia University Irving Medical Center, New York, New York, United States of America.
  • Karaaslan LE; Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York, United States of America.
  • Reshef R; Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York, United States of America.
  • Miko BA; Blood and Marrow Transplantation Program, Columbia University Irving Medical Center, New York, New York, United States of America.
  • Bathon JM; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York, United States of America.
  • Pereira MR; Division of Rheumatology, Department of Medicine, NewYork-Presbyterian Hospital, Columbia University Irving Medical Center, New York, New York, United States of America.
  • Uhlemann AC; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York, United States of America.
  • Yin MT; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York, United States of America.
  • Sobieszczyk ME; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York, United States of America.
PLoS One ; 16(4): e0249349, 2021.
Article em En | MEDLINE | ID: mdl-33831046
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Bacterianas / Surtos de Doenças / Anticorpos Monoclonais Humanizados / SARS-CoV-2 / COVID-19 / Tratamento Farmacológico da COVID-19 / Hospitais de Ensino Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Bacterianas / Surtos de Doenças / Anticorpos Monoclonais Humanizados / SARS-CoV-2 / COVID-19 / Tratamento Farmacológico da COVID-19 / Hospitais de Ensino Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos